About
Icarus Therapeutics is a San Diego-based TechBio company running an AI-powered clinical trial enrollment and patient-matching platform that uses generative AI/LLMs to match patients to trial criteria for pharma, biotech sponsors and CROs.
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Icarus Therapeutics
Icarus Therapeutics is a San Diego-based TechBio company running an AI-powered clinical trial enrollment and patient-matching platform that uses generative AI/LLMs to match patients to trial criteria for pharma, biotech sponsors and CROs.
—
United States
BusinessLatest roundTotal raisedDate- Alleviate Health
AI agents for clinical trial patient recruitment and screening
Seed · $4M · 2025-10
$4M - TJM Labs
AI automation platform for pharmacies, with AI agents handling prescription intake, refills and patient communication.
Series B · $100M · 2026-07
$100M - Archy
All-in-one cloud platform for dental practices: scheduling, patient communication, EHR and imaging, insurance verification and claims, billing and payments, and team management in one system, with native AI agents automating insurance, clinical documentation, patient communication and operations, replacing patchworks of legacy on-premise software.
Series C · $97M · 2026-09
$97M
China
BusinessLatest roundTotal raisedDateEurope
BusinessLatest roundTotal raisedDate- Iomed
NLP-based data extraction from medical records, clinical trials and patient surveys
Series A · $11M · 2023-09
$11M - Tucuvi
Voice AI that automates clinical follow-up and care management workflows
Series A · $184M · 2026-01
$184M - Praxipal
AI "front desk/receptionist" that automates patient communications for clinics
Seed · $7M · 2025-10
$7M
Other / unspecified
BusinessLatest roundTotal raisedDate- Reliant AI
Uses generative AI to help biopharma companies organize and analyze data for clinical trials or scientific publications
Seed · $11M · 2024-08
$11M - Lumonus AI
Workflow and knowledge management automation for radiation oncology departments (AI Physician)
Series B · $16M · 2025-11
$16M - Revena
Hospital billing automation
Seed · $8M · 2026-02
$8M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Andreessen Horowitz
25 Life Sciences deals in the last 24 months · 23 in US West Coast
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.